Speaker illustration

Doctor Takahide Kadosaka

Hokkaido University, Sapporo (Japan)

Member of:

European Society of Cardiology

Empagliflozin attenuates arrhythmogenesis via inhibition of O-GlcNAcylation in diastolic phase of diabetic cardiomyopathy.

Event: ESC Congress 2022

Topic: Arrhythmias

Session: Mechanisms of ventricular arrhythmias

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb